9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)

• 1. 9-氨基甲基米诺环素化合物及其在治疗社区获得性细菌性肺炎(CABP)中的用途 [P] . 中国专利： CN110087655A . 2019-08-02
• 2. 9-氨基甲基米诺环素化合物及其在泌尿道感染(UTI)治疗中的应用方法 [P] . 中国专利： CN109414445A . 2019-03-01
• 3. 9-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP) [P] . 美国专利： US2020009162A1 . 2020-01-09

  机译： 9-氨基甲基米诺环素化合物及其在治疗社区获得性细菌性肺炎（CABP）中的用途

• 4. 9-aminomethyl minocycline compounds and use thereof in treating Community-Acquired Bacterial Pneumonia (CABP) [P] . AU2017353588A1 . 2019-06-20

  机译： 9-氨基甲基米诺环素化合物及其在治疗社区获得性细菌性肺炎（CABP）中的用途

• 5. 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USE THEREOF IN TREATING COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP). [P] . MX2019005070A . 2019-09-23

  机译： 9-氨基甲基多环化合物及其在治疗社区获得性肺炎（CABP）中的用途。

• 1. Establishment of a Predictive Diagnostic Model for Acute Mycoplasma Pneumoniae Infection in Elderly Patients with Community-acquired Pneumonia [J] . XIAO Hong Li, XIN De Li, WANG Yan, 生物医学与环境科学（英文版） . 2017,第007期
• 2. Evaluating the Health Risks of Pneumonia from Airborne Bacterial Communities Using 16S rDNA Sequences of Pneumonia-related Pathogens [J] . GUO Jian Guo, KONG Qi, LIU Ce, 生物医学与环境科学（英文版） . 2021,第004期
• 3. Correlation Between the Clinical Severity, Bacterial Load, and Inflammatory Reaction in Children with Mycoplasma Pneumoniae Pneumonia [J] . Chen ZHANG, Qiao ZHANG, Jie-lin DU, 当代医学科学(英文) . 2020,第005期
• 4. Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial [J] . Sandra McCurdy, Ashley Nenninger, Amanda Sheets, International journal of infectious diseases : . 2020,第3S1期
• 5. Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP) [J] . Guervil David J., Kaye Keith S., Hassoun Ali, Journal of chemotherapy . 2016,第3期
• 6. A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP) [J] . Juan P Horcajada, Robert A Salata, Rodolfo álvarez-Sala, Open Forum Infectious Diseases . 2020,第1期
• 7. Bacterial clearance from blood in mice infected by S. pneumoniae (penicillin MIC=16 μg/ml) presenting specific IgG (non-protective levels) and treated with sub-therapeutic regimens of cefditoren (a highly bound cephalosporin) [C] . Fabio Cafini, Jose Yuste, Maria-Jose Giménez, International Conference on Antimicrobial Research . 2011
• 8. To treat or not to treat: The role of antibiotics in the management of community-acquired respiratory tract infections in an ambulatory setting. [D] . Deangelis, Julie Ann. 2008
• 9. 699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results [O] . James H Lewis, Anita F Das, Daniel Stein, -1
• 10. 699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results [O] . James H Lewis, Anita F Das, Daniel Stein, 2019

• 1. Clinical Utility of Procalcitonin for Differentiating between Cryptogenic Organizing Pneumonia and Community-Acquired Pneumonia [J] . Satoshi Takeda ,Nobuhiko Nagata ,Hiroyuki Miyazaki . 临床医学国际期刊（英文） . 2015,第6期
• 2. Lymphoid interstitial pneumonia—Another consideration for recurrent bacterial pneumonia in an HIV positive patient (A case report) [J] . Kevin Persaud ,Che Harris ,Shweta Ramsahai . 临床医学病理报告（英文） . 2013,第1期
• 3. 2,7-二甲基-9-羟基-占吨-9-羧酸酯类化合物的合成 [C] . 李叔损 . 中国化学会第一届有机化学学术会议暨第七届有机合成学术会议,第八届物理有机学术会议,第六届天然有机学术会议 . 1997
• 4. 2-氨基-9-(3-乙酰氧甲基丁基)嘌呤的合成及其应用于环境病毒灭活的研究 [A] . 曾莉 . 2018